NORMAN TAYLOR: Open Payments
NPI 1811937469 · MONTGOMERY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,835 in 80 payments from 25 companies in 2025. Trend: 2023 $2,479 · 2024 $2,232 · 2025 $1,835
Food & beverage: $1,835
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 15 | $271 |
| Alnylam Pharmaceuticals Inc. | 7 | $222 |
| Amgen Inc. | 7 | $174 |
| Novo Nordisk Inc | 8 | $168 |
| LEO Pharma Inc. | 1 | $149 |
| AstraZeneca Pharmaceuticals LP | 7 | $140 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $89 |
| Abbott Laboratories | 5 | $85 |
| ViiV Healthcare Company | 1 | $72 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $56 |
Products named: AMVUTTRA, ANZUPGO, UPLIZNA, ELIQUIS, Kerendia, VYNDAQEL, FREESTYLE LIBRE 3, WAINUA.
Industry payments across AL — which companies pay providers there.
